Dose Escalating Study for Amphinex-based PCI of Bleomycin.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cutaneous or Sub-cutaneous Malignancies
Interventions: DRUG: Amphinex|DRUG: Bleomycin|DEVICE: Laser
Sponsor: PCI Biotech AS